MedTrace Logo

Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users

NCT05501444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2023-04-13

No results posted yet for this study

Summary

The aim of the present pilot study is to evaluate the effect of antiperspirant to treat residual limb hyperhidrosis with the emphasis on the utility of the iodine-starch test to identify the location of the sweating.

Conditions

  • Hyperhidrosis
  • Residual Limbs

Interventions

OTHER

Topical antiperspirant

The participants will be instructed to use topical antiperspirant (aluminum chloride, 15 percent every evening for four weeks. The PI will contact the participants every week. If the participant experiences that antiperspirant have an effect, the use of antiperspirant will be reduced from daily use to 3 times a week.

Sponsors & Collaborators

  • Sophies Minde Ortopedi

    lead INDUSTRY

Principal Investigators

  • Jette Schack, PhD · Sophies Minde Ortopedi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-09
Primary Completion
2022-12-31
Completion
2023-03-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05501444 on ClinicalTrials.gov